HOLX vs. PHG, QGEN, CUTR, GEHC, LH, BAX, AVTR, ILMN, ALNY, and COO
Should you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Koninklijke Philips (PHG), Qiagen (QGEN), Cutera (CUTR), GE HealthCare Technologies (GEHC), Laboratory Co. of America (LH), Baxter International (BAX), Avantor (AVTR), Illumina (ILMN), Alnylam Pharmaceuticals (ALNY), and Cooper Companies (COO).
Hologic (NASDAQ:HOLX) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.
Hologic has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
Hologic received 483 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.76% of users gave Hologic an outperform vote while only 56.69% of users gave Koninklijke Philips an outperform vote.
Hologic has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.
In the previous week, Koninklijke Philips had 2 more articles in the media than Hologic. MarketBeat recorded 11 mentions for Koninklijke Philips and 9 mentions for Hologic. Hologic's average media sentiment score of 1.05 beat Koninklijke Philips' score of 0.40 indicating that Hologic is being referred to more favorably in the media.
Hologic currently has a consensus price target of $85.60, indicating a potential upside of 14.10%. Given Hologic's stronger consensus rating and higher probable upside, equities research analysts plainly believe Hologic is more favorable than Koninklijke Philips.
Hologic has a net margin of 11.78% compared to Koninklijke Philips' net margin of -4.41%. Hologic's return on equity of 18.91% beat Koninklijke Philips' return on equity.
94.7% of Hologic shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 1.8% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Hologic beats Koninklijke Philips on 16 of the 18 factors compared between the two stocks.
Get Hologic News Delivered to You Automatically
Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
